Logo image of AVCR.CA

AVRICORE HEALTH INC (AVCR.CA) Stock Fundamental Analysis

TSX-V:AVCR - TSX Venture Exchange - CA0545211090 - Common Stock - Currency: CAD

0.055  +0.01 (+22.22%)

Fundamental Rating

4

Overall AVCR gets a fundamental rating of 4 out of 10. We evaluated AVCR against 6 industry peers in the Health Care Technology industry. While AVCR has a great health rating, there are worries on its profitability. While showing a medium growth rate, AVCR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AVCR has reported negative net income.
AVCR had a positive operating cash flow in the past year.
AVCR had negative earnings in each of the past 5 years.
AVCR had negative operating cash flow in 4 of the past 5 years.
AVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFAVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

AVCR's Return On Assets of -0.11% is amongst the best of the industry. AVCR outperforms 83.33% of its industry peers.
Looking at the Return On Equity, with a value of -0.13%, AVCR belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA -0.11%
ROE -0.13%
ROIC N/A
ROA(3y)-44.78%
ROA(5y)-282.29%
ROE(3y)-51.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCR.CA Yearly ROA, ROE, ROICAVCR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

AVCR has a Gross Margin (36.16%) which is in line with its industry peers.
AVCR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AVCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5YN/A
AVCR.CA Yearly Profit, Operating, Gross MarginsAVCR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K

More info and screens

7

2. Health

2.1 Basic Checks

AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVCR has more shares outstanding than it did 1 year ago.
AVCR has more shares outstanding than it did 5 years ago.
AVCR has a worse debt/assets ratio than last year.
AVCR.CA Yearly Shares OutstandingAVCR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
AVCR.CA Yearly Total Debt VS Total AssetsAVCR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -1.55, we must say that AVCR is in the distress zone and has some risk of bankruptcy.
AVCR has a Altman-Z score of -1.55. This is in the better half of the industry: AVCR outperforms 66.67% of its industry peers.
AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -1.55
ROIC/WACCN/A
WACC10.24%
AVCR.CA Yearly LT Debt VS Equity VS FCFAVCR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M -2M 3M

2.3 Liquidity

AVCR has a Current Ratio of 2.79. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
AVCR has a better Current ratio (2.79) than 100.00% of its industry peers.
AVCR has a Quick Ratio of 2.76. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.76, AVCR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 2.76
AVCR.CA Yearly Current Assets VS Current LiabilitesAVCR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.91% over the past year.
The Revenue has grown by 64.21% in the past year. This is a very strong growth!
The Revenue has been growing by 196.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.24%
Revenue 1Y (TTM)64.21%
Revenue growth 3Y372.68%
Revenue growth 5Y196.15%
Sales Q2Q%90.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCR.CA Yearly Revenue VS EstimatesAVCR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCR.CA Price Earnings VS Forward Price EarningsAVCR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than AVCR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AVCR is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 57.67
EV/EBITDA 10.61
AVCR.CA Per share dataAVCR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVRICORE HEALTH INC

TSX-V:AVCR (4/23/2025, 7:00:00 PM)

0.055

+0.01 (+22.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-28 2024-11-28
Earnings (Next)05-06 2025-05-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.17%
Ins Owner ChangeN/A
Market Cap5.57M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.24
P/FCF 57.67
P/OCF 6.56
P/B 2.45
P/tB 2.51
EV/EBITDA 10.61
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY1.73%
OCF(TTM)0.01
OCFY15.25%
SpS0.04
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -0.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.16%
FCFM 2.16%
ROA(3y)-44.78%
ROA(5y)-282.29%
ROE(3y)-51.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5YN/A
F-Score7
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 158.85%
Cap/Sales 16.82%
Interest Coverage N/A
Cash Conversion 180.44%
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 2.76
Altman-Z -1.55
F-Score7
WACC10.24%
ROIC/WACCN/A
Cap/Depr(3y)561.25%
Cap/Depr(5y)N/A
Cap/Sales(3y)70.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%117.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.21%
Revenue growth 3Y372.68%
Revenue growth 5Y196.15%
Sales Q2Q%90.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y99.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.34%
OCF growth 3YN/A
OCF growth 5YN/A